Trials / Completed

CompletedNCT01102478

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg/25 mg Tablet Under Fasted Conditions

A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide Tablets 100 mg/25 mg Under Fasting Conditions

Status: Completed
Phase: N/A
Study type: Interventional
Enrollment: 30 (actual)

Sponsor: Roxane Laboratories · Industry
Sex: All
Age: 18 Years – 45 Years
Healthy volunteers: Accepted

Summary

The objective of this study was to prove the bioequivalence of Losartan Potassium/Hydrochlorothiazide 100/25 mg tablet under fasted conditions.

Conditions

Hypertension

Interventions

Type	Name	Description
DRUG	losartan potassium / hydrochlorothiazide	100 mg / 25 mg tablet

Timeline

Start date: 2005-02-01
Primary completion: 2005-03-01
Completion: 2005-03-01
First posted: 2010-04-13
Last updated: 2018-01-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01102478. Inclusion in this directory is not an endorsement.